Covered recipient · General Payments record
SEID ALI MIRMIRAN-YAZDY
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$7,226.85
- Reported across 240 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,166.80 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $512.25 | 12 |
| Medtronic, Inc. | $153.76 | 1 |
| Lilly USA, LLC | $138.81 | 4 |
| Janssen Biotech, Inc. | $137.25 | 2 |
| Phathom Pharmaceuticals, Inc. | $121.60 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $62.56 | 3 |
| Ferring Pharmaceuticals Inc. | $25.10 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $118.91 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044244 | CMS |
| ABBVIE INC. | $18.62 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044246 | CMS |
| ABBVIE INC. | $22.23 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044248 | CMS |
| ABBVIE INC. | $6.95 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044250 | CMS |
| ABBVIE INC. | $12.37 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044252 | CMS |
| ABBVIE INC. | $3.79 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044254 | CMS |
| ABBVIE INC. | $122.80 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044256 | CMS |
| ABBVIE INC. | $116.86 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044258 | CMS |
| ABBVIE INC. | $22.40 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044260 | CMS |
| ABBVIE INC. | $22.95 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044262 | CMS |
| ABBVIE INC. | $22.95 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044264 | CMS |
| ABBVIE INC. | $21.42 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105044266 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.47 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147018672 | CMS |
| Ferring Pharmaceuticals Inc. | $25.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137496106 | CMS |
| Janssen Biotech, Inc. | $14.37 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078631261 | CMS |
| Janssen Biotech, Inc. | $122.88 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078631991 | CMS |
| Lilly USA, LLC | $18.14 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135345656 | CMS |
| Lilly USA, LLC | $98.13 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135345660 | CMS |
| Lilly USA, LLC | $8.69 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135383735 | CMS |
| Lilly USA, LLC | $13.85 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135383733 | CMS |
| Medtronic, Inc. | $153.76 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119312038 | CMS |
| Phathom Pharmaceuticals, Inc. | $121.60 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151097371 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.43 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137636672 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.56 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137636674 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.57 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137636676 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.